Deborah A. O'neil

Silverburn Crescent, Bridge Of Don
Aberdeen, SCT AB238EW, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.

Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.

Journal: Biochemical and biophysical research communications

Published: June 12, 2023

Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures.

Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures.

Journal: ACS infectious diseases

Published: June 10, 2021

Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa.

Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa.

Journal: Frontiers in cellular and infection microbiology

Published: May 31, 2021

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.

Journal: Antimicrobial agents and chemotherapy

Published: May 25, 2021

Buried Treasure: Contradictions in the Perception and Reality of Women's Leadership.

Buried Treasure: Contradictions in the Perception and Reality of Women's Leadership.

Journal: Frontiers in psychology

Published: March 23, 2021

Innovation in infectious disease therapies from immunology.

Innovation in infectious disease therapies from immunology.

Journal: Drug discovery today

Published: December 02, 2020

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.

Journal: PloS one

Published: July 10, 2020

Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.

Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.

Journal: Frontiers in immunology

Published: May 30, 2020

Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.

Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.

Journal: Frontiers in cellular and infection microbiology

Published: March 06, 2020

NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.

NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.

Journal: Medical mycology

Published: December 19, 2019

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.

Journal: Antimicrobial agents and chemotherapy

Published: October 05, 2018

Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".

Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".

Journal: Antimicrobial agents and chemotherapy

Published: February 25, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026